To determine which respiratory viruses circulate among confined dogs, we analyzed nasal and pharyngeal swab specimens from shelter dogs with acute respiratory disease. An unknown virus was isolated. Monoclonal antibody testing indicated that it was probably a pneumovirus. PCR and sequence analysis indicated that it was closely related to murine pneumovirus.
Domestic dogs housed in close confinement, as in kennels or animal shelters, are often involved in outbreaks of acute respiratory disease (
Nasal and pharyngeal swab specimens were collected from the dogs, and swab eluate extracts were prepared. Pooled extracts were added to monolayer cultures of canine A72 cells (American Type Culture Collection, CRL-1542). After 3 passages in culture, cells in some of the flasks showed subtle cytopathic changes. After continued passage, small foci of rounded cells developed, and rapid and progressive cell death throughout the flask ensued in a pattern uncharacteristic of the viruses commonly isolated from dogs. Testing these cultures with a panel of diagnostic reagents specific for common canine respiratory agents failed to identify a known virus. Immunofluorescence assays (IFAs) ultimately detected 13 positive cultures over a 4-month period when a monoclonal antibody (MAb) pool against human respiratory syncytial virus (RSV) (VP-R151, Vector Laboratories, Burlingame, CA, USA) was used. We have commonly used this antibody preparation to detect bovine RSV. The staining pattern included filamentous membrane-bound and free-floating virions and cytoplasmic inclusions, typical of the pattern in RSV-infected cells.
After obtaining IFA results, we attempted to amplify a fragment of the nucleocapsid gene (N) from the virus by using PCR primers designed on the basis of an alignment of human, bovine, and ovine RSV sequences. This attempt was unsuccessful (data not shown). Stocks of the individual MAbs in the anti-RSV pool and their specificities were obtained from the manufacturer and used for IFA (
Slides showing immunofluorescence of A72 cells with human respiratory syncytial virus monoclonal antibodies (MAbs). A) MAb 2G122 on infected cells. B) MAb 2G122 on uninfected cells. C) MAb 5H5N on infected cells. D) MAb 5H5N on uninfected cells. Primary MAb stocks were used as obtained from the manufacturer at a dilution of 1:100. The red background is produced by counterstaining with Evans blue dye. Original magnification ×200.
To elucidate sequence information from 1 of the 13 isolates, we used a consensus-degenerate hybrid oligonucleotide primer algorithm to design degenerate PCR primers based on highly conserved amino acid sequences within multiple sequence alignments of all viruses in the subfamily
| Region sequenced† | PCR primers (5′ → 3′) and aa target sequences in pneumoviruses | % Identity to MPV, nt, aa† | % Identity to HRSV, nt, aa‡ | % Identity to HMPV, nt, aa§ |
|---|---|---|---|---|
| N gene,¶ nt 852–1182 (331 bp) | P1R: ggaactcgggggcgaayttytccat
target: MEKFAPEFH
N276F: tccgtgcaggccgaratggarcarg
target: SVQAEMEQV | 96.4, 96.3 | 68.5, 70.1 | 56.5, 54.1 |
| L gene, no. 1,¶ nt 1143–1452 (310 bp) | L428F: ccggatcttcggccayccnatggt
target: RIFGHPMV
L538R: ttcttaggaggggagatggcyttrtcrtt
target: NDKAISPPKN | 95.8, 97.1 | 62.1, 55.3 | 58.9, 47.6 |
| L gene, no. 2,¶ nt 1962–2511 (550 bp) | L698F: catcaccgacctgtccaagttyaaycargc target: ITDLSKFNQA L894R: ttgaagtcgtccaggatggtrttdatcca target: WINTILDDFK | 96.7, 99.5 | 68.4, 71.6 | 66.4, 68.3 |
*MPV, murine pneumovirus; nt, nucleotide; aa, amino acid; HRSV, human respiratory syncytial virus; HMPV, human metapneumovirus; N, nucleocapsid; R, reverse primer; F, forward primer L, polymerase. †Based on comparison with MPV strain J3666, GenBank accession no. NC_006579. ‡Based on comparison with HRSV, GenBank accession no. NC_001803. §Based on comparison with HMPV, GenBank accession no. NC_004148. ¶The N gene fragment is entered under GenBank accession no. GU247050; L gene fragments nos. 1 and 2 are entered under GenBank accession no. GU247051.
MPV is 1 of only 3 virus species classified in the family
The nucleotide identity between virus isolated from the dogs and MPV was consistently >95% throughout the gene regions examined. Because the degenerate primers used were designed to cover regions that are generally highly conserved, regions of the genome that are typically more variable in other pneumoviruses may show greater differences between the canine pneumovirus and MPV. Of the conserved regions sequenced, amino acid identities were 70% (N), 55% (L fragment no. 1), and 72% (L fragment no. 2) when aligned with the same regions of human RSV, so finding cross-reactivity between human RSV MAbs and the newly isolated virus is not completely unexpected. Serologic cross-reactivity between RSV and MPV has been previously observed. Gimenez et al. (
The isolation of a previously unknown virus from dogs does not imply disease causation. However, comparison with MPV leads to speculation that the virus isolated in this study may have pathogenic potential. MPV is commonly known to infect laboratory rodent colonies, and serologic evidence points to infection of several wild rodent species. However, little is known about MPV epidemiology, such as whether MPV has multiple natural hosts or whether closely related viruses are circulating in other species. Neutralizing antibodies to MPV in other mammalian species, including humans, were first reported in the 1940s (
Questions remain as to whether this newly isolated virus commonly infects dogs and, if so, why it has not been previously isolated. Perhaps the strain that was circulating in these particular animal shelters is more easily isolated in culture. Or, because the initial cytopathic changes observed with these isolates were subtle, they could easily have been missed. Outbreaks of acute respiratory disease in dogs often involve multiple pathogens. As anticipated, other viruses, primarily canine influenza and parainfluenza viruses, were isolated during the study, often from the same animals that carried the pneumovirus. Work is ongoing to further determine pneumovirus prevalence among dogs and its involvement in acute respiratory disease of dogs.
We thank Rebecca Harman, Jacqueline Nattrass, and Carol Nelson for their excellent technical assistance with diagnostic specimens.
This work was supported by departmental funding from the Animal Health Diagnostic Center at Cornell University.
Dr Renshaw is a molecular virologist at the Animal Health Diagnostic Center at Cornell University. His interests include identification, characterization, and development of diagnostic detection methods for viruses that infect domestic and wild animal species.